← Back to Clinical Trials
Recruiting NCT07477483

NCT07477483 Effect of Manuel Therapy on Tension Type Headache in Menopausal and Premenopasual Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07477483
Status Recruiting
Phase
Sponsor Necmettin Erbakan University
Condition Tension Type Headache
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-10-01
Primary Completion 2026-05

Eligibility & Interventions

Sex Female only
Min Age 45 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Manuel Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-10-01 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effectiveness of manual therapy in women with tension-type headache and to compare treatment outcomes between menopausal and premenopausal women. Hormonal changes occurring during menopause may influence pain perception and headache characteristics. Participants diagnosed with tension-type headache will receive manual therapy interventions. Headache intensity, headache-related disability, pressure pain threshold, cervical range of motion, sleep quality, and quality of life will be evaluated before and after treatment using validated assessment tools. The results are expected to contribute to physiotherapy approaches in women experiencing tension-type headache during different hormonal periods.

Eligibility Criteria

Inclusion Criteria: * Female participants aged between 45 and 65 years. * Diagnosis of tension-type headache. * Premenopausal or menopausal status. * HIT-6 score of 49 or higher. * Willingness to participate in the study. Exclusion Criteria: * Use of hormone therapy. * History of cervical surgery. * History of neurological disease. * Pregnancy. * Inability to understand questionnaire forms. * Failure to attend treatment sessions.

Contact & Investigator

Central Contact

Ayça Seda Yıldırımer, PT, MSc

✉ aycaseda29@gmail.com

📞 +90 507 409 08 99

Principal Investigator

Neslihan Altuntaş Yılmaz, PhD

PRINCIPAL INVESTIGATOR

Necmettin Erbakan University

Frequently Asked Questions

Who can join the NCT07477483 clinical trial?

This trial is open to female participants only, aged 45 Years or older, up to 65 Years, studying Tension Type Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07477483 currently recruiting?

Yes, NCT07477483 is actively recruiting participants. Contact the research team at aycaseda29@gmail.com for enrollment information.

Where is the NCT07477483 trial being conducted?

This trial is being conducted at Konya, Turkey (Türkiye).

Who is sponsoring the NCT07477483 clinical trial?

NCT07477483 is sponsored by Necmettin Erbakan University. The principal investigator is Neslihan Altuntaş Yılmaz, PhD at Necmettin Erbakan University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology